These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26773845)

  • 1. CJD and Scrapie Require Agent-Associated Nucleic Acids for Infection.
    Botsios S; Manuelidis L
    J Cell Biochem; 2016 Aug; 117(8):1947-58. PubMed ID: 26773845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly infectious CJD particles lack prion protein but contain many viral-linked peptides by LC-MS/MS.
    Kipkorir T; Tittman S; Botsios S; Manuelidis L
    J Cell Biochem; 2014 Nov; 115(11):2012-21. PubMed ID: 24933657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 25 nm virion is the likely cause of transmissible spongiform encephalopathies.
    Manuelidis L
    J Cell Biochem; 2007 Mar; 100(4):897-915. PubMed ID: 17044041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclease resistant circular DNAs copurify with infectivity in scrapie and CJD.
    Manuelidis L
    J Neurovirol; 2011 Apr; 17(2):131-45. PubMed ID: 21165784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic analysis of host brain components that bind to infectious particles in Creutzfeldt-Jakob disease.
    Kipkorir T; Colangelo CM; Manuelidis L
    Proteomics; 2015 Sep; 15(17):2983-98. PubMed ID: 25930988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replication and spread of CJD, kuru and scrapie agents in vivo and in cell culture.
    Miyazawa K; Emmerling K; Manuelidis L
    Virulence; 2011; 2(3):188-99. PubMed ID: 21527829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rapid accurate culture assay for infectivity in Transmissible Encephalopathies.
    Liu Y; Sun R; Chakrabarty T; Manuelidis L
    J Neurovirol; 2008 Oct; 14(5):352-61. PubMed ID: 18989813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The kuru infectious agent is a unique geographic isolate distinct from Creutzfeldt-Jakob disease and scrapie agents.
    Manuelidis L; Chakrabarty T; Miyazawa K; Nduom NA; Emmerling K
    Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13529-34. PubMed ID: 19633190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid chemical decontamination of infectious CJD and scrapie particles parallels treatments known to disrupt microbes and biofilms.
    Botsios S; Tittman S; Manuelidis L
    Virulence; 2015; 6(8):787-801. PubMed ID: 26556670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High CJD infectivity remains after prion protein is destroyed.
    Miyazawa K; Emmerling K; Manuelidis L
    J Cell Biochem; 2011 Dec; 112(12):3630-7. PubMed ID: 21793041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cells infected with scrapie and Creutzfeldt-Jakob disease agents produce intracellular 25-nm virus-like particles.
    Manuelidis L; Yu ZX; Barquero N; Mullins B
    Proc Natl Acad Sci U S A; 2007 Feb; 104(6):1965-70. PubMed ID: 17267596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two Creutzfeldt-Jakob disease agents reproduce prion protein-independent identities in cell cultures.
    Arjona A; Simarro L; Islinger F; Nishida N; Manuelidis L
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8768-73. PubMed ID: 15161970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of protein kinase MARK4 in the brains of experimental scrapie rodents and human prion disease correlates with deposits of PrP(Sc).
    Gong HS; Guo Y; Tian C; Xie WL; Shi Q; Zhang J; Xu Y; Wang SB; Zhang BY; Chen C; Liu Y; Dong XP
    Int J Mol Med; 2012 Sep; 30(3):569-78. PubMed ID: 22692785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral particles are required for infection in neurodegenerative Creutzfeldt-Jakob disease.
    Manuelidis L; Sklaviadis T; Akowitz A; Fritch W
    Proc Natl Acad Sci U S A; 1995 May; 92(11):5124-8. PubMed ID: 7761460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into prion strains and neurotoxicity.
    Aguzzi A; Heikenwalder M; Polymenidou M
    Nat Rev Mol Cell Biol; 2007 Jul; 8(7):552-61. PubMed ID: 17585315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human prion diseases: from Kuru to variant Creutzfeldt-Jakob disease.
    Sikorska B; Liberski PP
    Subcell Biochem; 2012; 65():457-96. PubMed ID: 23225013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative recovery of scrapie agent with minimal protein from highly infectious cultures.
    Sun R; Liu Y; Zhang H; Manuelidis L
    Viral Immunol; 2008 Sep; 21(3):293-302. PubMed ID: 18788938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dementias, neurodegeneration, and viral mechanisms of disease from the perspective of human transmissible encephalopathies.
    Manuelidis L
    Ann N Y Acad Sci; 1994 Jun; 724():259-81. PubMed ID: 8030947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agent-specific Shadoo responses in transmissible encephalopathies.
    Miyazawa K; Manuelidis L
    J Neuroimmune Pharmacol; 2010 Mar; 5(1):155-63. PubMed ID: 20112073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular assessment of the potential transmissibilities of BSE and scrapie to humans.
    Raymond GJ; Hope J; Kocisko DA; Priola SA; Raymond LD; Bossers A; Ironside J; Will RG; Chen SG; Petersen RB; Gambetti P; Rubenstein R; Smits MA; Lansbury PT; Caughey B
    Nature; 1997 Jul; 388(6639):285-8. PubMed ID: 9230438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.